Reports

Drug name	NICE TAs	Comments
Ergocalciferol capsules (Osto D2)
Ergocalciferol injection
Ergometrine maleate
Ergometrine maleate and oxytocin (syntometrine)
Erlotinib tablets	TA162 - Erlotinib for the treatment of non-small-cell lung cancer TA374 - Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy TA258 - Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer TA295 - Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy
Esmolol injection		Hospital only
Esomeprazole injection		Hospital use only
Etamsylate		Hospital use only
Etanercept	TA103 - Etanercept and efalizumab for the treatment of adults with psoriasis
Etanercept syringe	TA199 - Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis TA195 - Drugs for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor TA375 - Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed TA715 - Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed

University Hospitals Birmingham NHS Foundation Trust